Inspire Medical Systems Inc. and two of its top executives allegedly concealed issues with prior authorization for insurance coverage of its implantable sleep apnea therapy device, a shareholder class action lawsuit says.
The company allegedly misled investors for six months, failing to disclose that customers were encountering challenges with submitting for prior authorization and scheduling appointments, which led to a shortfall in hundreds of procedures to implant the device, according to the complaint filed Dec. 22 in US District Court for the District of Minnesota.
Patients seeking to receive insurance coverage for Inspire’s sleep apnea therapy are required to visit ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.